Induction of Labor in Morbidly Obese Patients
EARLY_PHASE1
162
about 2.3 years
18+
Female only
1 site in MD
What this study is about
This trial is testing whether different doses of Misoprostol (25 mcg or 50 mcg) are effective at inducing labor in women with morbid obesity. The goal is to see if using a higher dose of Misoprostol can improve the chances of vaginal delivery compared to a lower dose, especially in this population.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Misoprostol
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
misoprostol
oral (Oral Tablet)
Secondary: Number of patients with tachysystole with non reassuring fetal heart rate (NRFHT)
Endocrinology, Reproductive Health